PADI4 and psoriasis: In the presented study, the concentrations of NET protein–PAD-4 and its main stimulus factor, TNFα, were analyzed before and during (week 4 and 12) the application of three types of systemic therapy used in patients with psoriasis: MTX, anti-TNFα and anti-IL 17a.